It is noteworthy that ablation of HIF1a in the pancreatic tissue dramatically boosts malignant progress of KrasG12D-driven PanIN by recruiting a specific subgroup of B cells to infiltrate into the tumor microenvironment [29]. This evidence concerns the gene HIF1A and neoplasm.